Does ERIBULIN Cause Therapy partial responder? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Therapy partial responder have been filed in association with ERIBULIN (eribulin mesylate). This represents 0.3% of all adverse event reports for ERIBULIN.
16
Reports of Therapy partial responder with ERIBULIN
0.3%
of all ERIBULIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapy partial responder From ERIBULIN?
Of the 16 reports, 3 (18.8%) required hospitalization, and 3 (18.8%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERIBULIN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which ERIBULIN Alternatives Have Lower Therapy partial responder Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE